Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Trending on PharmExec

FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents

What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them

Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing

Pharmaceutical Executive: December 2025 Interactive Digital Edition

Articles in this issue

Newsletter

Trending on PharmExec

FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents

What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them

Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing

Conflict in Middle East Disrupts Pharma Drug Supplies: Report

What Governance Resets Should Pharma Companies Take in Response to AI?